Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study.
Nørgaard K, Scaramuzza A, Bratina N, Lalić NM, Jarosz-Chobot P, Kocsis G, Jasinskiene E, De Block C, Carrette O, Castañeda J, Cohen O; Interpret Study Group. Nørgaard K, et al. Among authors: castaneda j. Diabetes Technol Ther. 2013 Apr;15(4):273-80. doi: 10.1089/dia.2012.0288. Epub 2013 Feb 25. Diabetes Technol Ther. 2013. PMID: 23438304 Free PMC article.
The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy.
Conget I, Battelino T, Giménez M, Gough H, Castañeda J, Bolinder J; SWITCH Study Group. Conget I, et al. Among authors: castaneda j. Diabetes Technol Ther. 2011 Jan;13(1):49-54. doi: 10.1089/dia.2010.0107. Diabetes Technol Ther. 2011. PMID: 21175271 Free article. Clinical Trial.
OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods.
Aronson R, Cohen O, Conget I, Runzis S, Castaneda J, de Portu S, Lee S, Reznik Y; OpT2mise Study Group. Aronson R, et al. Among authors: castaneda j. Diabetes Technol Ther. 2014 Jul;16(7):414-20. doi: 10.1089/dia.2013.0363. Epub 2014 Apr 15. Diabetes Technol Ther. 2014. PMID: 24735134 Clinical Trial.
Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study.
Hommel E, Olsen B, Battelino T, Conget I, Schütz-Fuhrmann I, Hoogma R, Schierloh U, Sulli N, Gough H, Castañeda J, de Portu S, Bolinder J; SWITCH Study Group. Hommel E, et al. Among authors: castaneda j. Acta Diabetol. 2014 Oct;51(5):845-51. doi: 10.1007/s00592-014-0598-7. Epub 2014 Jul 19. Acta Diabetol. 2014. PMID: 25037251 Free PMC article. Clinical Trial.
The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.
Conget I, Castaneda J, Petrovski G, Guerci B, Racault AS, Reznik Y, Cohen O, Runzis S, de Portu S, Aronson R; OpT2mise Study Group. Conget I, et al. Among authors: castaneda j. Diabetes Technol Ther. 2016 Jan;18(1):22-8. doi: 10.1089/dia.2015.0159. Epub 2015 Aug 4. Diabetes Technol Ther. 2016. PMID: 26241790 Free PMC article. Clinical Trial.
Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: An analysis from the OpT2mise randomized trial.
Metzger M, Castañeda J, Reznik Y, Giorgino F, Conget I, Aronson R, de Portu S, Runzis S, Lee SW, Cohen O. Metzger M, et al. Among authors: castaneda j. Diabetes Obes Metab. 2017 Oct;19(10):1490-1494. doi: 10.1111/dom.12960. Epub 2017 Jul 25. Diabetes Obes Metab. 2017. PMID: 28374511 Clinical Trial.
238 results